Life sciences Life sciences AC Immune and Takeda sign USD 100 million deal to treat Alzheimer’s disease 13 May 2024
Life sciences Ikerian, parent company of RetinAI, secures USD 6.18 million for AI-driven medical advancements 13 May 2024
Life sciences Nanobacterie secures strategic investment from EP Equity to advance prostate cancer treatment 6 May 2024
Life sciences Life sciences UniBe spin-off Risklick unveils AI tool to streamline clinical trials 29 April 2024
Life sciences Isospec pioneers rapid diagnostic technologies with USD 1.9 million funding 22 April 2024
Life sciences Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment 9 April 2024